440 related articles for article (PubMed ID: 15740861)
1. Clinical and serological follow-up in dogs with visceral leishmaniosis treated with allopurinol and sodium stibogluconate.
Pasa S; Toz SO; Voyvoda H; Ozbel Y
Vet Parasitol; 2005 Mar; 128(3-4):243-9. PubMed ID: 15740861
[TBL] [Abstract][Full Text] [Related]
2. Comparison of different tissue sampling for PCR-based diagnosis and follow-up of canine visceral leishmaniosis.
Manna L; Vitale F; Reale S; Caracappa S; Pavone LM; Morte RD; Cringoli G; Staiano N; Gravino AE
Vet Parasitol; 2004 Nov; 125(3-4):251-62. PubMed ID: 15482882
[TBL] [Abstract][Full Text] [Related]
3. Study of efficacy of miltefosine and allopurinol in dogs with leishmaniosis.
Manna L; Vitale F; Reale S; Picillo E; Neglia G; Vescio F; Gravino AE
Vet J; 2009 Dec; 182(3):441-5. PubMed ID: 18818112
[TBL] [Abstract][Full Text] [Related]
4. Real-time PCR assay in Leishmania-infected dogs treated with meglumine antimoniate and allopurinol.
Manna L; Reale S; Vitale F; Picillo E; Pavone LM; Gravino AE
Vet J; 2008 Aug; 177(2):279-82. PubMed ID: 17553711
[TBL] [Abstract][Full Text] [Related]
5. Use of allopurinol to treat visceral leishmaniosis in a dog.
Lester SJ; Kenyon JE
J Am Vet Med Assoc; 1996 Aug; 209(3):615-7. PubMed ID: 8755981
[TBL] [Abstract][Full Text] [Related]
6. Nodular lesions of the tongue in canine leishmaniosis.
Parpaglia ML; Vercelli A; Cocco R; Zobba R; Manunta ML
J Vet Med A Physiol Pathol Clin Med; 2007 Oct; 54(8):414-7. PubMed ID: 17877582
[TBL] [Abstract][Full Text] [Related]
7. PCR follow-up examination after treatment of canine leishmaniosis (CaL).
Steuber S; Moritz A; Schirrmann I; Greiner M
Tokai J Exp Clin Med; 1998 Dec; 23(6):285-92. PubMed ID: 10622624
[TBL] [Abstract][Full Text] [Related]
8. Canine visceral leishmaniasis: comparison of in vitro leishmanicidal activity of marbofloxacin, meglumine antimoniate and sodium stibogluconate.
Vouldoukis I; Rougier S; Dugas B; Pino P; Mazier D; Woehrlé F
Vet Parasitol; 2006 Jan; 135(2):137-46. PubMed ID: 16242844
[TBL] [Abstract][Full Text] [Related]
9. Periodic administration of allopurinol is not effective for the prevention of canine leishmaniosis (Leishmania infantum) in the endemic areas.
Saridomichelakis MN; Mylonakis ME; Leontides LS; Billinis C; Koutinas AF; Galatos AD; Gouletsou P; Diakou A; Kontos VI
Vet Parasitol; 2005 Jun; 130(3-4):199-205. PubMed ID: 15905034
[TBL] [Abstract][Full Text] [Related]
10. Problems in the treatment of kala-azar: case report.
Nyakundi PM; Rashid JR; Wasunna KM; Were JB; Muigai R; Kirigi G; Mbugua J
East Afr Med J; 1995 Jun; 72(6):406-8. PubMed ID: 7498017
[TBL] [Abstract][Full Text] [Related]
11. Use of domperidone in the treatment of canine visceral leishmaniasis: a clinical trial.
Gómez-Ochoa P; Castillo JA; Gascón M; Zarate JJ; Alvarez F; Couto CG
Vet J; 2009 Feb; 179(2):259-63. PubMed ID: 18023375
[TBL] [Abstract][Full Text] [Related]
12. Immunotherapy with the saponin enriched-Leishmune vaccine versus immunochemotherapy in dogs with natural canine visceral leishmaniasis.
Borja-Cabrera GP; Santos FN; Santos FB; Trivellato FA; Kawasaki JK; Costa AC; Castro T; Nogueira FS; Moreira MA; Luvizotto MC; Palatnik M; Palatnik-de-Sousa CB
Vaccine; 2010 Jan; 28(3):597-603. PubMed ID: 19800443
[TBL] [Abstract][Full Text] [Related]
13. Treatment of canine leishmaniosis with aminosidine at an optimized dosage regimen: a pilot open clinical trial.
Athanasiou LV; Saridomichelakis MN; Kontos VI; Spanakos G; Rallis TS
Vet Parasitol; 2013 Feb; 192(1-3):91-7. PubMed ID: 23140991
[TBL] [Abstract][Full Text] [Related]
14. Clinical follow-up examination after treatment of canine leishmaniasis.
Moritz A; Steuber S; Greiner M
Tokai J Exp Clin Med; 1998 Dec; 23(6):279-83. PubMed ID: 10622623
[TBL] [Abstract][Full Text] [Related]
15. [Canine leishmaniasis: evolution of the chemotherapeutic protocols].
Oliva G; Foglia Manzillo V; Pagano A
Parassitologia; 2004 Jun; 46(1-2):231-4. PubMed ID: 15305724
[TBL] [Abstract][Full Text] [Related]
16. Long-term follow-up of dogs with leishmaniosis treated with meglumine antimoniate plus allopurinol versus miltefosine plus allopurinol.
Manna L; Corso R; Galiero G; Cerrone A; Muzj P; Gravino AE
Parasit Vectors; 2015 May; 8():289. PubMed ID: 26017164
[TBL] [Abstract][Full Text] [Related]
17. Polyarthritis associated with visceral leishmaniasis in a juvenile dog.
Santos M; Marcos R; Assunção M; Matos AJ
Vet Parasitol; 2006 Nov; 141(3-4):340-4. PubMed ID: 16824686
[TBL] [Abstract][Full Text] [Related]
18. Epidemiological aspects of canine visceral leishmaniosis in the Islamic Republic of Iran.
Mohebali M; Hajjaran H; Hamzavi Y; Mobedi I; Arshi S; Zarei Z; Akhoundi B; Naeini KM; Avizeh R; Fakhar M
Vet Parasitol; 2005 May; 129(3-4):243-51. PubMed ID: 15845279
[TBL] [Abstract][Full Text] [Related]
19. [Canine leishmaniasis from Leishmania infantum: value and production of the latex test. Ecoepidemiologic applications].
Dereure J; Lanotte G; Pratlong F; Gouvernet J; Majhour J; Belazzoug S; Khiami A; Rageh HA; Jarry D; Périères J; Rioux JA
Bull Soc Pathol Exot; 1998; 91(4):300-5. PubMed ID: 9846221
[TBL] [Abstract][Full Text] [Related]
20. Interferon-gamma (INF-gamma), IL4 expression levels and Leishmania DNA load as prognostic markers for monitoring response to treatment of leishmaniotic dogs with miltefosine and allopurinol.
Manna L; Reale S; Picillo E; Vitale F; Gravino AE
Cytokine; 2008 Nov; 44(2):288-92. PubMed ID: 18842424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
